Biotechnology and medical technology „Made in Regensburg"
(No. 280) BioPark Regensburg GmbH, an enterprise of the city of Regensburg, and the patent law firm Dehmel & Bettenhausen based there have again awarded two innovation prizes of €1,500 to outstanding research work in 2024.
The jury, consisting of BioPark Managing Director Dr. Thomas Diefenthal, patent attorney Dr. Berthold Bettenhausen, Prof. Dr. Bernhard Weber from the University of Regensburg and Prof. Dr. Klaudia Winkler from the East Bavarian Institute of Technology Regensburg (OTH Regensburg), once again had a difficult time selecting this year's winners from the high-quality applications. The decisive criteria were the innovative strength and the application and start-up potential of the work.
Ms. Sandra Friedrich received a BioPark Innovation Prize 2024 for her research work on the development of a new rapid test for the insecticidal effect of potential active substances in crop protection products as part of her master's thesis at the university's Institute for Analytical Chemistry, Chemo- and Biosensorics. The test can be used in the development of new pesticides to identify potential active substances that have a harmful effect on insects in the early stages of development. It can make an important contribution to reducing insect mortality and therefore increasing agricultural productivity, which is closely linked to the pollination performance of insects. The new assay is based on using insect cells as holistic sensors and obtaining a readout on the influence of pesticides on the vitality of these cells in real time and with high throughput in multiwell plates using a microelectronic process. The process is currently being further automated in cooperation with the local Fraunhofer working group for Electronic Microsystems and Solid State Technologies (EMFT) under Prof. Dr. Joachim Wegner. Ms. Friedrich is currently undertaking her doctorate under Prof. Wegner at the University of Regensburg to further develop the method (contact: sandra.friedrich@chemie.uni-regensburg.de)
Dr. Moritz Burger received another BioPark Innovation Award 2024 for the development of an innovative implant and implantation system for the minimally invasive treatment of isolated orbital floor fractures. These fractures of the orbital floor, often caused by accidents and falls, are currently treated using a lower eyelid approach that is fraught with complications. Dr. Burger developed the implant and implantation system for a novel, minimally invasive treatment procedure for these fractures in his doctoral thesis at the Regensburg Center of Biomedical Engineering (RCBE), a cross-faculty and cross-university research facility of the East Bavarian Institute of Technology Regensburg (OTH) and the University of Regensburg with the University Hospital. In the medical device laboratory of Prof. Dr. Thomas Schratzenstaller, Dr. Burger developed the implant using clinical CT data in order to be able to depict the anatomy and the novel access route in detail in the design. The manufacturability of the implant was successfully demonstrated using laser fine cutting and the implantation system using injection molding. The industrial research partner Gerresheimer Regensburg GmbH provided support in this regard. The innovative implantation system via the nasal passage into the maxillary sinus enables minimally invasive insertion and placement of the implant, which significantly improves patient care. A patent for the entire system has been successfully registered. (Contact: burger.moritz93@web.de)
BioPark CEO Dr. Thomas Diefenthal (r) with winner of the BioPark Innovation Award 2024 Ms. Sandra Friedrich (l)
(© BioPark Regensburg GmbH)
BioPark CEO Dr. Thomas Diefenthal (r) with winner of the BioPark Innovation Award 2024 Dr. Moritz Burger (l)
(© BioPark Regensburg GmbH)
For further information see